Table of Contents: Hematologic Malignancy Special Edition - 2005
Thalidomide Analog for Relapsed, Refractory Myeloma
STEVEN SCHEY, Guy's Hospital, London
[04:05 min:sec]
Bortezomib Responses in Mantle Cell and Follicular Lymphoma
OWEN O'CONNOR, Memorial Sloan-Kettering Cancer Center, New York
[05:37 min:sec]
Saar - Rituximab-CHOP in Younger, Low-Risk Patients with Diffuse Large B-Cell Lymphoma
MICHAEL PFREUNDSCHUH, Universitätskliniken des Saarland, Homburg
[05:34 min:sec]
SGN 30 New Anti CD-30 Monoclonal Antibody for Patients with Anaplastic Large Cell Lymphoma
MICHAEL MCDONALD, Seattle Genetics, Bothel
[05:28 min:sec]
Essential Thrombocythemia Old Treatment Better than New!
TONY GREEN, University of Cambridge
[05:59 min:sec]
Can Gentler Therapy for Patients with Hodgkin's Disease Work Just as Well
VOLKER DIEHL, University Hospital of Heidelberg
[07:26 min:sec]
BMS 354 825 for Imatinib-Resistant Chronic Myeloid Leukemia
CHARLES SAWYERS, University of California, Los Angeles
[05:59 min:sec]
AMN 107 for Patients with Chronic Myeloid Leukemia Resistant to Imatinib
FRANCIS GILES, M D Anderson Cancer Center, Houston
[04:05 min:sec]
Thalidomide New Study Shows Benefit in Multiple Myeloma
S. VINCENT RAJKUMAR, Mayo Clinic, Rochester
[04:41 min:sec]
Immunochemotherapy plus Transplant Best for Patients with Mantle Cell Lymphoma in First Remission
MARTIN DREYLING, Hospital Grosshadern, Munich
[04:34 min:sec]
Follicular Lymphoma Treated with Ibritumomab Tiuxetan
JOHN SWEETENHAM, Arizona Cancer Center, Tucson
[04:31 min:sec]
Sud - Rituximab-CHOP Significantly Better than CHOP Alone for Elderly Patients with Diffuse Large B-Cell Lymphoma
BERTRAND COIFFIER, Centre Hospitalier Lyon
[02:17 min:sec]
Lymphoma The Next Questions - Conference Review
JOHN SWEETENHAM, Arizona Cancer Center, Tucson
[10:27 min:sec]
Listen to this audio by subscribing to the Podcast |
|---|
Copy and paste the URL below into a podcasting program [How To] http://www.asco.org/pc/ajo/hema05.xml |